Tessera Therapeutics

Today, we're excited to announce new preclinical data presented at the American Society of Gene & Cell Therapy Annual Meeting in Boston, highlighting significant advances across our in vivo SCD program and CAR-T applications. Read the full announcement here: https://lnkd.in/e8jX39TG

Join us at the American Society of Gene & Cell Therapy 2026 Annual Meeting! Our team is looking forward to presenting new preclinical data highlighting advancements in our sickle cell disease program and in vivo CAR-T applications.    📍 If you're attending ASGCT this year, we look forward to connecting and sharing more about our latest progress. 

Last week, we were reminded exactly who our work is for.   We had the privilege of welcoming two patient speakers from the Alpha-1 Foundation to our office. Both are living with Alpha-1 Antitrypsin Deficiency and spoke about their journeys to diagnosis and their day-to-day experiences with the disease.   They shared their stories with #TeamTessera and what a potential cure could truly mean.   We are grateful for the trust they placed in us. Their stories, and those of others living with Alpha-1, are why we show up every day to pioneer the #FutureOfGeneticMedicine.   #Alpha1Awareness #RareDisease #GeneWriting

We're looking forward to sharing new preclinical data at the upcoming American Society of Gene & Cell Therapy Annual Meeting. Our presentations will feature progress in our in vivo sickle cell disease program and continued advancement of our in vivo CAR-T approaches. Learn more here: https://lnkd.in/e435uZKA #ASGCT26

This #WomensHistoryMonth, our Women in Tessera (WIT) ERG organized a series of programs centered on mentorship, career development, and workplace equity. Throughout the month, these efforts created space to build leadership skills and explore self-advocacy, mentorship across a career, and how we can better recognize and challenge unconscious bias in everyday decisions. Building an environment where people can learn from one another, grow, and contribute fully is essential to advancing both people and science. #TeamTessera #Community #Leadership

Today, we're excited to share that we've received a grant from the Gates Foundation to advance our in vivo Gene Writing approaches toward a potential scalable cure for HIV. Read the full announcement here: https://lnkd.in/ejaSKBnr

By writing in the code of life through our #GeneWriting platform, we’re pursuing new ways to address major unmet needs in rare genetic diseases. In recognition of #RareDiseaseDay, #TeamTessera came together to support the rare disease community by writing letters to patients and families. We were also honored to hear from Dr. Sonia Vallabh, a scientist at the Broad Institute of MIT and Harvard, whose journey is a powerful reminder of the urgency and humanity behind the work to create cures for rare diseases. #RareDiseaseDay #RareGeneticDisease  

Today, we're excited to announce that we received U.S. FDA Fast Track and Orphan Drug Designation for our lead in vivo gene editing program, TSRA-196, for the treatment of AATD.     Read the full announcement here: https://lnkd.in/euNva5pE

As we recognize Black History Month, we honor the voices and contributions of the Black community. Cynthia Patton, General Counsel and Secretary, shares how this month shapes the way she reflects and leads. At Tessera, we are committed to fostering an inclusive workplace where every voice is valued, this month and every day. #BlackHistoryMonth #TeamTessera #Inclusion

In honor of International Day of Women and Girls in Science, we are celebrating the women across #TeamTessera who bring curiosity, rigor, and courage to discovery, and the allies who help open doors for the next generation. Members of our team joined colleagues for a fireside chat with Sally Kornbluth, President of MIT, followed by an evening of connection. We are reminded that progress is powered not only by breakthrough ideas, but by the people behind them who lead, mentor, and make space for others to thrive. #WomenInScience #IDWGS2026